Another 8x Risk to Reward Stock (SBFM)
Updated
SBFM About
Sunshine Biopharma, Inc. is a New York-based pharmaceutical company that develops and commercializes oncology and antiviral drugs, as well as science-based nutritional supplements. Their products include treatments for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006.
Recent News
Stock Split April 17th, 2024
5 Point Inspection by OnePunchman:
- Free Float shares: 953.39 K - Positive
- Cash & equivalents: 16.29 M - Positive
- Debt: 657.71 K - Positive
- Last Quarter Revenue:7.68M - Positive compared to Cash in hand and Free Float
- Prescriptions Drugs are in the market - https://sunshinebiopharma.com/prescription-drugs/
Buy Alert done by Fibonacci retracement levels:
Price: $3.20
- Entire Position Stop Loss: $2.91
- 1st Take Profit: $5.30 (I would sell 50% of my holdings here) - Risk to Reward Ratio is x8
- 2nd Take Profit: $8.79 (I would sell 30% of my holdings here) - Risk to Reward Ratio is x21
- 3rd Take Profit: $10.25 (I would sell 20% of my remaining holdings here) - Risk to Reward Ratio is x27
Trade closed: stop reached
Please subscribe to the channel at youtube.com/c/onepunchalgo to receive alerts via short videos for daily US stock trades.
Till we reach 1000 subscribers, we will post 1 stock per week after that we will post 1 stock every day.
Till we reach 1000 subscribers, we will post 1 stock per week after that we will post 1 stock every day.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.